S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
OTCMKTS:CVALF

Covalon Technologies (CVALF) Stock Price, News & Analysis

$0.89
+0.04 (+4.72%)
(As of 03/28/2024 ET)
Today's Range
$0.89
$0.89
50-Day Range
$0.80
$0.96
52-Week Range
$0.73
$1.58
Volume
400 shs
Average Volume
1,290 shs
Market Capitalization
$22.24 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
CVALF stock logo

About Covalon Technologies Stock (OTCMKTS:CVALF)

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company's platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity. It also offers medical coating platform, a process that utilizes photo-polymerization to create active grafting sites where new polymer chains are initiated and propagated from the surface of an existing medical device. In addition, the company provides wound care dressings; surgical and peri-operative; and infection management products. It offers its products under the Covalon brand name through third-party distribution networks and company's direct sales force. The company serves hospitals, wound care centers, burn centers, extended/alternate care and acute care facilities, home health care agencies, and physicians' offices. Covalon Technologies Ltd. is headquartered in Mississauga, Canada.

CVALF Stock Price History

CVALF Stock News Headlines

Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
Covalon Announces First Quarter Fiscal 2024 Results
Covalon Announces Leadership Changes
Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
Covalon Announces Third Quarter Fiscal 2023 Results
See More Headlines
Receive CVALF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Covalon Technologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/28/2024
Today
3/29/2024
Next Earnings (Estimated)
5/23/2024
Fiscal Year End
9/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Health services
Sub-Industry
N/A
Current Symbol
OTCMKTS:CVALF
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-3,310,000.00
Pretax Margin
-16.77%

Debt

Sales & Book Value

Annual Sales
$19.72 million
Book Value
$0.56 per share

Miscellaneous

Free Float
N/A
Market Cap
$22.24 million
Optionable
Not Optionable
Beta
-0.56
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Mr. Brian E. Pedlar
    President & Director
  • Mr. Ronald Hebert
    Senior Vice President of Growth
  • Mr. Amir Boloor CFA
    Executive Chairman
  • Mr. Brent Ashton
    CEO & Director
  • Dr. Valerio DiTizio (Age 56)
    Co-Founder, Chief Scientific Officer & VP
    Comp: $131.43k
  • Ms. Katie Martinovich
    Interim Chief Financial Officer
  • Ms. Kim Crooks
    Senior Vice President of Operations
  • Mr. Greg Leszczynski
    Vice President of Human Resources
  • Gerry Arambula
    President of Covalon Technologies AG Ltd.
  • Mr. Hamed Abbasian
    Vice President of Business Development

CVALF Stock Analysis - Frequently Asked Questions

How have CVALF shares performed in 2024?

Covalon Technologies' stock was trading at $0.77 on January 1st, 2024. Since then, CVALF stock has increased by 15.2% and is now trading at $0.8870.
View the best growth stocks for 2024 here
.

When is Covalon Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 23rd 2024.
View our CVALF earnings forecast
.

How were Covalon Technologies' earnings last quarter?

Covalon Technologies Ltd. (OTCMKTS:CVALF) released its quarterly earnings results on Wednesday, February, 28th. The company reported ($0.02) EPS for the quarter. The company had revenue of $3.43 million for the quarter. Covalon Technologies had a negative net margin of 19.70% and a negative trailing twelve-month return on equity of 23.88%.

How do I buy shares of Covalon Technologies?

Shares of CVALF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:CVALF) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners